Have your own idea? Try our Stock Screener
UPDATED Nov 19, 2024
Discover U.S. Pharmaceuticals & Biotech Growth Stocks that are on the NYSE and NASDAQ. Sorted by forecasted growth, these Pharmaceuticals & Biotech Stocks have higher than expected earnings or sales growth compared to other companies.
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
PHIO | US$2.55 | 8.6% | -69.5% | US$2.2m | US$36.00 | PB0.4x | E221.7% | n/a | ||
BHC | US$8.19 | -6.7% | 19.2% | US$3.0b | US$8.57 | PE-16.9x | E218.3% | n/a | ||
CRMD | US$11.07 | -2.5% | 202.5% | US$671.7m | US$14.25 | PS54.8x | E183.4% | n/a | ||
AMRX | US$8.44 | -6.5% | 89.7% | US$2.6b | US$10.50 | PE-14.2x | E156.0% | 0% | ||
CSBR | US$4.55 | -1.1% | -17.3% | US$61.9m | US$6.00 | PS1.2x | E146.9% | n/a | ||
SNDL | US$1.98 | 1.0% | 33.8% | US$525.7m | US$3.49 | PB0.6x | E146.1% | n/a | ||
CDMO | US$12.19 | -0.08% | 124.1% | US$779.6m | US$13.00 | PS5.5x | E139.0% | n/a | ||
CADL | US$3.99 | -7.0% | 343.3% | US$129.6m | US$11.00 | PE-2.5x | E138.9% | n/a | ||
AZTA | US$40.91 | -8.1% | -28.7% | US$1.9b | US$56.60 | PS2.8x | E125.6% | 0% | ||
MLAB | US$99.75 | -7.4% | 13.5% | US$541.8m | US$140.00 | PS2.4x | E124.8% | 0.6% | ||
EVOK | US$4.70 | 10.3% | -68.8% | US$7.5m | US$18.00 | PB1.7x | E124.7% | n/a | ||
ORGO | US$4.08 | -7.9% | 57.5% | US$540.9m | US$4.70 | PS1.2x | E123.3% | n/a | ||
PLX | US$1.63 | 31.5% | 15.6% | US$119.9m | US$14.00 | PS2.6x | E118.3% | n/a | ||
CTKB | US$6.13 | -9.6% | -8.5% | US$789.6m | US$8.40 | PS3.9x | E114.8% | n/a | ||
ANIK | US$17.04 | 0% | -17.2% | US$249.6m | US$26.50 | PS1.5x | E108.3% | n/a | ||
YCBD | US$0.45 | -0.6% | -31.8% | US$1.7m | US$2.00 | PB0.6x | E107.9% | n/a | ||
AQB | US$0.98 | -4.2% | -53.7% | US$3.8m | US$1.00 | PS3x | E105.9% | n/a | ||
CKPT | US$3.38 | -6.6% | 61.7% | US$152.2m | US$17.00 | PS3237.5x | E102.7% | n/a | ||
ENSC | US$0.68 | -4.4% | -22.3% | US$9.4m | US$6.80 | PS2.1x | E102.6% | n/a | ||
ALVO | US$12.50 | 4.8% | 37.0% | US$3.8b | US$17.40 | PS9.6x | E101.2% | n/a | ||
EBS | US$8.27 | -17.1% | 295.7% | US$448.1m | US$12.00 | PB0.9x | E98.5% | n/a | ||
CDNA | US$22.06 | -3.2% | 124.4% | US$1.2b | US$34.67 | PS3.8x | E95.0% | n/a | ||
VNDA | US$4.92 | -9.9% | 40.2% | US$286.9m | US$10.43 | PS1.5x | E86.9% | n/a | ||
MRVI | US$4.63 | -17.8% | -10.4% | US$1.2b | US$9.73 | PS2.4x | E84.7% | n/a |